Oberheide A, van den Oetelaar M, Scheele J, Borggrafe J, Engelen S, Sattler M
RSC Med Chem. 2025; .
PMID: 40070456
PMC: 11892739.
DOI: 10.1039/d4md00833b.
Katz L, Visser E, Plitzko K, Pennings M, Cossar P, Tse I
Nat Commun. 2025; 16(1):2110.
PMID: 40025013
PMC: 11873037.
DOI: 10.1038/s41467-025-57241-7.
London N
Chem Rev. 2024; 125(1):326-368.
PMID: 39692621
PMC: 11719315.
DOI: 10.1021/acs.chemrev.4c00570.
Andlovic B, Valenti D, Centorrino F, Picarazzi F, Hristeva S, Hiltmann M
Biochemistry. 2024; 63(17):2196-2206.
PMID: 39172504
PMC: 11375770.
DOI: 10.1021/acs.biochem.4c00248.
Vickery H, Virta J, Konstantinidou M, Arkin M
SLAS Discov. 2024; 29(5):100165.
PMID: 38797286
PMC: 11774552.
DOI: 10.1016/j.slasd.2024.100165.
Molecular glues for protein-protein interactions: Progressing toward a new dream.
Konstantinidou M, Arkin M
Cell Chem Biol. 2024; 31(6):1064-1088.
PMID: 38701786
PMC: 11193649.
DOI: 10.1016/j.chembiol.2024.04.002.
Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity.
Katz L, Visser E, Plitzko K, Pennings M, Cossar P, Tse I
bioRxiv. 2024; .
PMID: 38405965
PMC: 10888794.
DOI: 10.1101/2024.02.16.580675.
A simple method for developing lysine targeted covalent protein reagents.
Gabizon R, Tivon B, Reddi R, van den Oetelaar M, Amartely H, Cossar P
Nat Commun. 2023; 14(1):7933.
PMID: 38040731
PMC: 10692228.
DOI: 10.1038/s41467-023-42632-5.
Targeted Reversible Covalent Modification of a Noncatalytic Lysine of the Krev Interaction Trapped 1 Protein Enables Site-Directed Screening for Protein-Protein Interaction Inhibitors.
Francisco K, Bruystens J, Varricchio C, McCurdy S, Wu J, Lopez-Ramirez M
ACS Pharmacol Transl Sci. 2023; 6(11):1651-1658.
PMID: 37974623
PMC: 10644391.
DOI: 10.1021/acsptsci.3c00156.
C-terminal modification and functionalization of proteins via a self-cleavage tag triggered by a small molecule.
Zeng Y, Shi W, Liu Z, Xu H, Liu L, Hang J
Nat Commun. 2023; 14(1):7169.
PMID: 37935692
PMC: 10630284.
DOI: 10.1038/s41467-023-42977-x.
Structure-Based Optimization of Covalent, Small-Molecule Stabilizers of the 14-3-3σ/ERα Protein-Protein Interaction from Nonselective Fragments.
Konstantinidou M, Visser E, Vandenboorn E, Chen S, Jaishankar P, Overmans M
J Am Chem Soc. 2023; 145(37):20328-20343.
PMID: 37676236
PMC: 10515640.
DOI: 10.1021/jacs.3c05161.
From Tethered to Freestanding Stabilizers of 14-3-3 Protein-Protein Interactions through Fragment Linking.
Visser E, Jaishankar P, Sijbesma E, Pennings M, Vandenboorn E, Guillory X
Angew Chem Int Ed Engl. 2023; 62(37):e202308004.
PMID: 37455289
PMC: 11287480.
DOI: 10.1002/anie.202308004.
Molecular Glue Discovery: Current and Future Approaches.
Dewey J, Delalande C, Azizi S, Lu V, Antonopoulos D, Babnigg G
J Med Chem. 2023; 66(14):9278-9296.
PMID: 37437222
PMC: 10805529.
DOI: 10.1021/acs.jmedchem.3c00449.
Protein-protein interactions: developing small-molecule inhibitors/stabilizers through covalent strategies.
Lucero B, Francisco K, Liu L, Caffrey C, Ballatore C
Trends Pharmacol Sci. 2023; 44(7):474-488.
PMID: 37263826
PMC: 11003449.
DOI: 10.1016/j.tips.2023.04.007.
What Makes a Good Protein-Protein Interaction Stabilizer: Analysis and Application of the Dual-Binding Mechanism.
Chen S, Zacharias M
ACS Cent Sci. 2023; 9(5):969-979.
PMID: 37252344
PMC: 10214505.
DOI: 10.1021/acscentsci.3c00003.
Reversible Dual-Covalent Molecular Locking of the 14-3-3/ERRγ Protein-Protein Interaction as a Molecular Glue Drug Discovery Approach.
Somsen B, Schellekens R, Verhoef C, Arkin M, Ottmann C, Cossar P
J Am Chem Soc. 2023; 145(12):6741-6752.
PMID: 36926879
PMC: 10064330.
DOI: 10.1021/jacs.2c12781.
Functional mapping of the 14-3-3 hub protein as a guide to design 14-3-3 molecular glues.
Somsen B, Craenmehr F, Liu W, Koops A, Pennings M, Visser E
Chem Sci. 2022; 13(44):13122-13131.
PMID: 36425501
PMC: 9667936.
DOI: 10.1039/d2sc04662h.
Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment.
Wu H, Yao H, He C, Jia Y, Zhu Z, Xu S
Acta Pharm Sin B. 2022; 12(9):3548-3566.
PMID: 36176907
PMC: 9513498.
DOI: 10.1016/j.apsb.2022.03.019.
Preclinical insights into fucoidan as a nutraceutical compound against perfluorooctanoic acid-associated obesity targeting endoplasmic reticulum stress.
Liu J, Guo C, Wang Y, Su M, Huang W, Lai K
Front Nutr. 2022; 9:950130.
PMID: 36034923
PMC: 9413161.
DOI: 10.3389/fnut.2022.950130.
Towards identification of protein-protein interaction stabilizers inhibitory peptide-fragment hybrids using templated fragment ligation.
Srdanovic S, Hegedus Z, Warriner S, Wilson A
RSC Chem Biol. 2022; 3(5):546-550.
PMID: 35656480
PMC: 9092428.
DOI: 10.1039/d2cb00025c.